The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of allogeneic natural killer cells in combination with pembrolizumab in patients with chemotherapy-refractory biliary tract cancer: A multicenter open-label phase 1/2a trial.
 
Galam Leem
No Relationships to Disclose
 
Sung Ill Jang
No Relationships to Disclose
 
Jae-Hee Cho
No Relationships to Disclose
 
Jung Hyun Jo
No Relationships to Disclose
 
Hee Seung Lee
No Relationships to Disclose
 
Moon Jae Chung
No Relationships to Disclose
 
Jeong Youp Park
No Relationships to Disclose
 
Seungmin Bang
No Relationships to Disclose
 
Da-Kyung Yoo
No Relationships to Disclose
 
Hyo-Cheon Cheon
No Relationships to Disclose
 
Jae-Eun Kim
No Relationships to Disclose
 
Kyeong-Pill Lim
No Relationships to Disclose
 
In-Hye Jung
No Relationships to Disclose
 
Jung-Min Im
No Relationships to Disclose
 
Yong Yoon Chung
No Relationships to Disclose
 
Seung Woo Park
No Relationships to Disclose